2 weeks Ago By Defense World Staff
APG Asset Management US Inc. increased its holdings in shares of Agilent Technologies, Inc. ( NYSE:A – Free Report ) by 2.
4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 84,391 shares of the medical research company’s stock after purchasing an additional 1,972 shares during the period. APG Asset Management US Inc.
’s holdings in Agilent Technologies were worth $10,751,000 as of its most recent SEC filing. Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc.
raised its stake in shares of Agilent Technologies by 18.2% during the first quarter. Vanguard Group Inc.
now owns 29,884,345 shares of the medical research company’s stock worth $4,348,471,000 after purchasing an additional 4,605,228 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in Agilent Technologies by 13.
9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,542,054 shares of the medical research company’s stock valued at $1,242,956,000 after buying an additional 1,042,926 shares during the period.
Massachusetts Financial Services Co. MA raised its position in Agilent Technologies by 5.7% during the 2nd quarter.
Massachusetts Financial Services Co. MA now owns 15,064,660 shares of the medical research company’s stock worth $1,952,832,000 after buying an additional 809,149 shares during the last quarter. Meritage Group LP lifted its stake in shares of Agilent Technologies by 28.
3% in the 4th quarter. Meritage Group LP now owns 2,116,862 shares of the medical research company’s stock worth $294,307,000 after acquiring an additional 467,451 shares during the period. Finally, Oribel Capital Management LP acquired a new position in shares of Agilent Technologies during the fourth quarter worth about $60,186,000.
Insider Activity In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.
00. Following the transaction, the chief executive officer now owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. The sale was disclosed in a filing with the SEC, which is available at the SEC website .
Agilent Technologies Trading Up 5.2 % Agilent Technologies ( NYSE:A – Get Free Report ) last released its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.
32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06.
The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion.
Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%.
The business’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.
43 earnings per share. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.
24 EPS for the current fiscal year. Agilent Technologies Dividend Announcement The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st will be issued a dividend of $0.
236 per share. The ex-dividend date is Tuesday, October 1st. This represents a $0.
94 dividend on an annualized basis and a dividend yield of 0.64%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.
22%. Analyst Upgrades and Downgrades A number of equities research analysts recently commented on A shares. JPMorgan Chase & Co.
reduced their price objective on shares of Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th.
Jefferies Financial Group restated a “hold” rating and issued a $135.00 price target (down from $152.00) on shares of Agilent Technologies in a research note on Monday, June 3rd.
TD Cowen increased their price objective on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd.
UBS Group boosted their target price on shares of Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd.
Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company’s stock.
According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $141.60.
Get Our Latest Stock Analysis on A Agilent Technologies Profile ( Free Report ) Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Read More Five stocks we like better than Agilent Technologies What Are the U.K. Market Holidays? How to Invest and Trade Rocket Lab Stock Soars: Should Investors Chase the Rally? What Is WallStreetBets and What Stocks Are They Targeting? KB Home Slips After Earnings: What’s Next for Homebuilders? How to Invest in the FAANG Stocks Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.
com's FREE daily email newsletter ..
